IBIO — iBio Balance Sheet
0.000.00%
- $9.97m
- $4.20m
- $0.23m
- 22
- 26
- 38
- 18
Annual balance sheet for iBio, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 55.1 | 97 | 33.5 | 4.3 | 14.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 5.62 | 5.53 | 6.1 | 0.204 | 0.713 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 61.7 | 105 | 45.1 | 26.3 | 15.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 31.3 | 34.7 | 41.8 | 7.55 | 6.37 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 94.2 | 147 | 99.4 | 41.2 | 28.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.24 | 6.64 | 30.4 | 21.6 | 3.84 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 37.6 | 38.4 | 35.9 | 25.8 | 7.41 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 56.6 | 109 | 63.5 | 15.4 | 21.3 |
Total Liabilities & Shareholders' Equity | 94.2 | 147 | 99.4 | 41.2 | 28.7 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |